Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Daniel H Zimmerman"'
Autor:
Daniel H. Zimmerman, Zoltan Szekanecz, Adrienn Markovics, Kenneth S. Rosenthal, Roy E. Carambula, Katalin Mikecz
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Rheumatoid arthritis (RA) is recognized as an autoimmune joint disease driven by T cell responses to self (or modified self or microbial mimic) antigens that trigger and aggravate the inflammatory condition. Newer treatments of RA employ monoclonal a
Externí odkaz:
https://doaj.org/article/e4aec4b93f5348f99a094ae2c4a12b9e
Autor:
Adrienn Markovics, Ken S. Rosenthal, Katalin Mikecz, Roy E. Carambula, Jason C. Ciemielewski, Daniel H. Zimmerman
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 44 (2021)
Rheumatoid arthritis (RA) and other autoimmune inflammatory diseases are examples of imbalances within the immune system (disrupted homeostasis) that arise from the effects of an accumulation of environmental and habitual insults over a lifetime, com
Externí odkaz:
https://doaj.org/article/aacb30cf19d94f53a97f82ad64f54b8a
Autor:
Ken S. Rosenthal, Daniel H. Zimmerman
Publikováno v:
AIMS Allergy and Immunology, Vol 1, Iss 2, Pp 89-100 (2017)
The J-LEAPS peptide vaccine platform allows development of vaccines that elicit antigen specific Th1 immune responses to the incorporated antigenic peptide by promoting the maturation of mouse and human precursors into type 1 dendritic cells (DC1). C
Externí odkaz:
https://doaj.org/article/bb5dfdf8af154894bbd9724612c07ab0
Autor:
Daniel H. Zimmerman, Katalin Mikecz, Adrienn Markovics, Roy E. Carambula, Jason C. Ciemielewski, Daniel M. Toth, Tibor T. Glant, Ken S. Rosenthal
Publikováno v:
Vaccines, Vol 9, Iss 5, p 448 (2021)
Rheumatoid arthritis (RA) can be initiated and driven by immune responses to multiple antigenic epitopes including those in cartilage proteoglycan (PG, aggrecan) and type II collagen. RA is driven by T helper 1 (Th1) or Th17 pro-inflammatory T cell r
Externí odkaz:
https://doaj.org/article/917db455b8474722af7ecbb433438e1f
Autor:
Adrienn Markovics, Ken S. Rosenthal, Katalin Mikecz, Roy E. Carambula, Jason C. Ciemielewski, Daniel H. Zimmerman
Publikováno v:
Biomedicines, Vol 10, Iss 44, p 44 (2022)
Biomedicines
Biomedicines
Rheumatoid arthritis (RA) and other autoimmune inflammatory diseases are examples of imbalances within the immune system (disrupted homeostasis) that arise from the effects of an accumulation of environmental and habitual insults over a lifetime, com
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
The prototype J-LEAPS T cell vaccine for HER-2/neu breast cancer (J-HER) consists of the murine HER-2/neu66–74 H-2d CD8 T cell epitope covalently attached through a triglycine linker to the J-immune cell binding ligand (ICBL) (human β2 microglobul
Externí odkaz:
https://doaj.org/article/3d37a31ef86b4931b9f4646381aef4ad
Autor:
Roy E. Carambula, Daniel H. Zimmerman, Tibor T. Glant, Ken S. Rosenthal, Daniel M. Toth, Adrienn Markovics, Katalin Mikecz, Jason C. Ciemielewski
Publikováno v:
Vaccines
Volume 9
Issue 5
Vaccines, Vol 9, Iss 448, p 448 (2021)
Volume 9
Issue 5
Vaccines, Vol 9, Iss 448, p 448 (2021)
Rheumatoid arthritis (RA) can be initiated and driven by immune responses to multiple antigenic epitopes including those in cartilage proteoglycan (PG, aggrecan) and type II collagen. RA is driven by T helper 1 (Th1) or Th17 pro-inflammatory T cell r
Autor:
Daniel H. Zimmerman, Ken S. Rosenthal
Publikováno v:
AIMS Allergy and Immunology, Vol 1, Iss 2, Pp 89-100 (2017)
The J-LEAPS peptide vaccine platform allows development of vaccines that elicit antigen specific Th1 immune responses to the incorporated antigenic peptide by promoting the maturation of mouse and human precursors into type 1 dendritic cells (DC1). C
Publikováno v:
Journal of clinicalcellular immunology. 10(1)
This review examines some of the reasons why we don’t have a vaccine against autoimmune diseases and highlights the progress that has been made. Many autoimmune diseases, such as rheumatoid arthritis (RA), multiple sclerosis (MS) and type 1 diabete
Publikováno v:
Int Immunopharmacol
Lessons can be learned for treating inflammatory diseases such as rheumatoid arthritis (RA) from next generation approaches for development of universal influenza vaccines. Immunomodulation of inflammatory diseases, rather than ablation of cytokine o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af3f61f9d3447c8092eb561c706906c4
https://europepmc.org/articles/PMC6719783/
https://europepmc.org/articles/PMC6719783/